
    
      This one-month research study examines how Fanapt® (iloperidone), Zyprexa® (olanzapine), or
      Risperdal® (risperidone) affect glucose metabolism in patients with schizophrenia,
      schizoaffective disorder, bipolar disorder, major depressive disorder, psychosis NOS,
      delusional disorder or paranoid disorder. This study requires 3 research visits and includes
      a physical exam, medical history, vitals, an EKG, cognitive testing, psychological rating
      scales, a DEXA scan, a nutritional assessment, a 3-hour intravenous glucose tolerance test
      (IVGTT) and a fasting blood draw.
    
  